Logo

Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian

Author(s):
Seyed Moayed AlavianSeyed Moayed Alavian1,*, Behzad HajarizadehBehzad Hajarizadeh2, Bashir HajibeigiBashir Hajibeigi2, Taher DoroudiTaher Doroudi2, Amir Kambiz HamadanizadehAmir Kambiz Hamadanizadeh2, Koroush AbarKoroush Abar2
1Baqiyatallah University of Medical Sciences, Tehran Hepatitis Center, Study Group of Interferonin Iran, [email protected], Tehran, IR.Iran
2Baqiyatallah University of Medical Sciences, Tehran Hepatitis center, Tehran, IR.Iran

Hepatitis Monthly:Vol. 4, issue 7; 53-58
Article type:Research Article
How to Cite:Alavian S M, Hajarizadeh B, Hajibeigi B, Doroudi T, Hamadanizadeh A K, et al. Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian.Hepat Mon.4(7):53-58.

Abstract

Full Text

Full text is available in PDF

Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles